Milestone Pharmaceuticals Inc. Operating Lease, Right-of-Use Asset, Amortization Expense
Milestone Pharmaceuticals Inc. (MIST) reported Operating Lease, Right-of-Use Asset, Amortization Expense of $581.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-20.
Financial Statements › Cash Flow › Operating Activities
us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense · last filed 2026-03-20
- Milestone Pharmaceuticals Inc. operating lease, right-of-use asset, amortization expense for fiscal 2025 was $581.00K, a 7.39% increase from fiscal 2024.
- Milestone Pharmaceuticals Inc. operating lease, right-of-use asset, amortization expense for fiscal 2024 was $541.00K, a 6.92% increase from fiscal 2023.
- Milestone Pharmaceuticals Inc. operating lease, right-of-use asset, amortization expense for fiscal 2023 was $506.00K, a 29.41% increase from fiscal 2022.
- Milestone Pharmaceuticals Inc. operating lease, right-of-use asset, amortization expense for fiscal 2022 was $391.00K, a 45.35% increase from fiscal 2021.
| Period end | Operating Lease, Right-of-Use Asset, Amortization Expense 12 month |
|---|---|
| 2025-12-31 | $581.00K 10-K · filed 2026-03-20 |
| 2024-12-31 | $541.00K 10-K · filed 2026-03-20 |
| 2023-12-31 | $506.00K 10-K · filed 2025-03-13 |
| 2022-12-31 | $391.00K 10-K · filed 2024-03-21 |
| 2021-12-31 | $269.00K 10-K · filed 2023-03-29 |
| 2020-12-31 | $279.00K 10-K · filed 2022-03-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Anixa Biosciences Inc (ANIX) | United States | $0.096B | |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B |